netFormulary
 Report : A-Z HCD items in Formulary 28/10/2020 22:39:52
[Back]
 
Section Status CCG Name
09.01.04 Formulary CCG Avatrombopag Doptelet®
04.12 Formulary CCG Botulinum neurotoxin type A Xeomin®
10.01.03 Restricted Use CCG Brodalumab Kyntheum ®
08.01.05 Formulary CCG Dupilumab 
06.01.02.03 Formulary CCG Ertugliflozin  Steglatro®
04.07.04.02 Formulary CCG Fremanezumab Ajovy®
10.01.03 Restricted Use CCG Golimumab Simponi®
13.05.03 Formulary CCG Guselkumab Tremfya ®
13.05.03 Formulary CCG Ixekizumab Taltz®
09.01.04 Formulary CCG Lusutrombopag Mulpleo®
09.02.01.01 Formulary CCG Patiromer  Veltassa®
07.04.03 Formulary CCG Pentosan polysulfate elmiron ®
13.05.02 Formulary CCG Risankizumab 
03.03.03 Formulary CCG Roflumilast Daxas®
09.02.01.01 Formulary CCG Sodium zirconium cyclosilicate Lokelma®
06.01.02.03 Formulary CCG Sotagliflozin 
13.05.03 Formulary CCG Tildrakizumab 
01.05.03 Formulary CCG Tofacitinib Xeljanz®
10.02.01 Formulary CCG Tofacitinib Xeljanz®
Birmingham, Sandwell, Solihull and environs APC Formulary